Eli Lilly profit drops sharply on Zyprexa generics
(Reuters) – Eli Lilly & Co's quarterly profit dropped 27 percent after its top-selling Zyprexa schizophrenia treatment lost U.S. patent protection and saw competition from generic rivals. The drugmaker backed its 2012 outlook that calls for a …
View full post on Yahoo! Health News
drops, generics, Lilly, Profit, sharply, Zyprexa